Clinical Trials on Hepatitis, Alcoholic in Belgium

Total 250 results

Erasme University Hospital

Unknown

Corticosteroids in Alcoholic Hepatitis

Alcoholic Hepatitis

Belgium
Erasme University Hospital

Completed

N-Acetylcysteine in Severe Acute Alcoholic Hepatitis

Alcoholic Hepatitis

Belgium
Erasme University Hospital

Completed

Intensive Enteral Nutrition and Acute Alcoholic Hepatitis

Severe Alcoholic Hepatitis

Belgium, France
Erasme University Hospital

Completed

Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease

Alcoholic Liver Disease | Chronic Hepatitis C Virus

Belgium
Erasme University Hospital

Completed

sgp130 in Chronic Human Liver Disease

Chronic Hepatitis C Virus Infection | Alcoholic Liver Disease

Belgium
University Hospital, Lille
Ministry of Health, France

Completed

Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis (CorpentoxHAA)

Alcoholic Liver Disease | Alcoholic Hepatitis

France, Belgium
University Hospital, Lille
Ministry of Health, France

Completed

Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment (QuickTrans)

Alcoholic Hepatitis | Alcoholic Cirrhosis

Belgium, France
Gilead Sciences

Completed

Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)

Alcoholic Hepatitis (AH)

Austria, United Kingdom, France, United States, Canada, Belgium, Switzerland
Durect
CTI Clinical Trial and Consulting Services

Completed

A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment (AHFIRM)

Alcoholic Hepatitis

United States, Australia, United Kingdom, France, Belgium, Austria
Erasme University Hospital

Completed

Influence of Adiponutrin in Chronic Liver Disease

Alcoholic Liver Disease

Belgium
Brugmann University Hospital
University Ghent; Université Libre de Bruxelles

Completed

Severe Alcohol-use Disorder: a tDCS and Response Inhibition Training Intervention (ALCOSTIM)

Alcohol Use Disorder

Belgium
Brugmann University Hospital

Recruiting

Neurofeedback Training of Metacognition in Subjects With Alcohol Use Disorder. Disorder Induces Neural Modifications: an Event-related Potentials Study

Alcohol Use Disorder

Belgium
Universitair Ziekenhuis Brussel

Unknown

Baclofen in Managing Acute Alcohol Withdrawal

Alcohol Use Disorder | Alcohol Withdrawal

Belgium
Brugmann University Hospital

Completed

Effect of Anti-craving Medication on Cognitive Functions in Alcohol Dependence: an ERP Study

Alcohol Dependence

Belgium
Université Catholique de Louvain

Recruiting

Impact of Omega 3 in Alcohol Use Disorder (W3-AUD)

Alcohol Use Disorder, Severe

Belgium
University Ghent
University of Amsterdam; PZ Heilig Hart; PZ Sint-Camillus

Completed

Research on the Efficacy of the "T.O.P. Computer Training" Procedure in the Treatment of Alcohol Dependence

Alcohol Dependence

Belgium
Universitair Ziekenhuis Brussel

Recruiting

Non-invasive Brain Stimulation of the Prefrontal Cortex in Substance Use Disorders (NIBSSUD)

Alcohol Use Disorder (AUD)

Belgium
Brugmann University Hospital

Completed

tDCS to Prevent Relapse in Alcohol Use Disorder

Active tDCS | Sham tDCS

Belgium
Université Catholique de Louvain

Unknown

Dietary Fiber Intake in Alcohol-dependent Patients

Alcoholism

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Endocrine Regulation of Energy and Fluid Supplies in Alcoholic Patients

Alcoholism

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease

Liver Disease | Alcohol Abuse

Belgium
Atea Pharmaceuticals, Inc.

Withdrawn

Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects

Hepatitis C Virus Infection | Hepatitis C | Hepatitis C, Chronic | Chronic Hepatitis C | HCV Infection

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis C

Hepatitis C, Chronic

Belgium
Centre Hospitalier Universitaire Saint Pierre
AbbVie; Gilead Sciences; Cepheid; Réseau Hépatite C Bruxelles

Completed

HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels

Hepatitis C, Chronic

Belgium
GlaxoSmithKline

Completed

A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays

Immunologic Tests

Belgium
GlaxoSmithKline

Completed

Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)

Hepatitis B Disease

Belgium
Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r)

Hepatitis C Virus

Belgium
Tibotec Pharmaceuticals, Ireland

Completed

A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen

Hepatitis C Virus

Belgium
Tibotec Pharmaceuticals, Ireland

Completed

A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus

Hepatitis C Virus

Belgium
Universitair Ziekenhuis Brussel

Recruiting

Relinking Diagnosed But Untreated HCV Patients Back Into Care. (Relink)

Hepatitis C Virus Infection

Belgium
Hasselt University

Recruiting

Screening for NAFLD in Flanders

Non-Alcoholic Fatty Liver Disease

Belgium
Brugmann University Hospital

Completed

Prevalence and Screening of Hepatitis C in Belgium in 2015

Hepatitis C

Belgium
Erasme University Hospital

Completed

Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial

Anxiety | Cirrhosis | Chronic Hepatitis

Belgium
Pfizer

Completed

Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State

Hepatitis C Virus

Belgium
Janssen Sciences Ireland UC

Completed

A Study to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

Hepatitis C, Chronic

Belgium
GlaxoSmithKline

Completed

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule

Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule

Hepatitis A

Belgium
Atea Pharmaceuticals, Inc.

Completed

Study of AT-527 in Healthy and HCV-Infected Subjects

Hepatitis C | Hepatitis C, Chronic | Chronic Hepatitis C

Belgium, Moldova, Republic of
Tibotec Pharmaceuticals, Ireland

Completed

TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients

Hepatitis C

Belgium
GlaxoSmithKline
Region of Wallonia; Public Private Partnership with Institute for Medical Immunology...

Completed

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium
Crucell Holland BV

Completed

Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine

Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium

3

Subscribe